Luka Nicin

718 total citations
12 papers, 389 citations indexed

About

Luka Nicin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Luka Nicin has authored 12 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Luka Nicin's work include Cardiac Fibrosis and Remodeling (5 papers), Congenital heart defects research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Luka Nicin is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), Congenital heart defects research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Luka Nicin collaborates with scholars based in Germany, United States and United Kingdom. Luka Nicin's co-authors include Stefanie Dimmeler, Andreas M. Zeiher, Lukas Tombor, David John, Wesley Abplanalp, Tomáš Holubec, Fabian Emrich, Badder Kattih, Mani Arsalan and Thomas Walther and has published in prestigious journals such as Circulation, PLoS ONE and FEBS Letters.

In The Last Decade

Luka Nicin

11 papers receiving 386 citations

Peers

Luka Nicin
Yumeko Kawano United States
Zihan Xia China
Ossama Abou Hassan United States
Alexander B. Pine United States
Luka Nicin
Citations per year, relative to Luka Nicin Luka Nicin (= 1×) peers Dimitrios Delialis

Countries citing papers authored by Luka Nicin

Since Specialization
Citations

This map shows the geographic impact of Luka Nicin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luka Nicin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luka Nicin more than expected).

Fields of papers citing papers by Luka Nicin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luka Nicin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luka Nicin. The network helps show where Luka Nicin may publish in the future.

Co-authorship network of co-authors of Luka Nicin

This figure shows the co-authorship network connecting the top 25 collaborators of Luka Nicin. A scholar is included among the top collaborators of Luka Nicin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luka Nicin. Luka Nicin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kattih, Badder, Lukas Tombor, Luka Nicin, et al.. (2024). Inhibition of miR-92a normalizes vascular gene expression and prevents diastolic dysfunction in heart failure with preserved ejection fraction. Journal of Molecular and Cellular Cardiology. 198. 89–98. 4 indexed citations
2.
Kattih, Badder, Mariana Shumliakivska, Lukas Tombor, et al.. (2023). Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease. Cardiovascular Research. 119(15). 2550–2562. 17 indexed citations
3.
Drenckhahn, Jörg‐Detlef, Luka Nicin, Anne Schänzer, et al.. (2023). Cardiomyocyte hyperplasia and immaturity but not hypertrophy are characteristic features of patients with RASopathies. Journal of Molecular and Cellular Cardiology. 178. 22–35. 3 indexed citations
4.
Luxán, Guillermo, et al.. (2022). The role of pericytes in cardiac ageing and disease. European Heart Journal. 43(Supplement_2). 2 indexed citations
5.
Wagner, Julian U. G., Denisa Bojková, Mariana Shumliakivska, et al.. (2021). Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants. Basic Research in Cardiology. 116(1). 42–42. 38 indexed citations
6.
Nicin, Luka, Wesley Abplanalp, Anne Schänzer, et al.. (2021). Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy. Circulation. 143(17). 1704–1719. 33 indexed citations
7.
Nicin, Luka, Julian U. G. Wagner, Guillermo Luxán, & Stefanie Dimmeler. (2021). Fibroblast‐mediated intercellular crosstalk in the healthy and diseased heart. FEBS Letters. 596(5). 638–654. 45 indexed citations
8.
Nicin, Luka, Wesley Abplanalp, Badder Kattih, et al.. (2020). Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. European Heart Journal. 41(19). 1804–1806. 206 indexed citations
9.
Nicin, Luka, Wesley Abplanalp, David John, et al.. (2020). Single nuclei sequencing reveals novel insights into cardiac cell signatures in human pediatric dilated cardiopathy. European Heart Journal. 41(Supplement_2). 1 indexed citations
10.
Wagner, Julian U. G., Minh Duc Pham, Luka Nicin, et al.. (2019). Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics. Journal of Molecular and Cellular Cardiology. 138. 269–282. 15 indexed citations
11.
Wagner, Nils, Kernt Köhler, Luka Nicin, et al.. (2018). Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release. PLoS ONE. 13(2). e0192171–e0192171. 16 indexed citations
12.
Chang, Alex Chia Yu, Luka Nicin, Gerhard Weber, et al.. (2018). An In Vitro Model for Identifying Cardiac Side Effects of Anesthetics. Anesthesia & Analgesia. 130(1). e1–e4. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026